AGM/EGMJun 25, 2026, 07:51 AM
Cardiol Therapeutics Reports 2026 Annual General Meeting Results
AI Summary
Cardiol Therapeutics Inc. announced the results of its Annual General Meeting of Shareholders (AGM) held virtually on June 24, 2026. Shareholders voted overwhelmingly in favour of all Management resolutions. This included the election of eight directors for the upcoming year and the re-appointment of BDO Canada LLP as the Company's auditors.
Key Highlights
- Shareholders overwhelmingly approved all Management resolutions proposed in the Management Information Circular.
- Eight directors were elected for the ensuing year, including Dr. Guillermo Torre-Amione, David Elsley, and Chris Waddick.
- BDO Canada LLP was re-appointed as the Company's auditors for the next fiscal year.
- Directors were authorized to fix the remuneration for the auditors.
- Dr. Guillermo Torre-Amione received 96.45% of votes cast for his election as director.
- David Elsley received 98.11% of votes cast for his election as director.
- Chris Waddick received 98.96% of votes cast for his election as director.
Price Impact
More from CRDL